Predictors of outcomes in patients on peritoneal dialysis: A 2-year nationwide cohort study

[1]  T. Hasegawa,et al.  Glycated albumin versus hemoglobin A1c and mortality in diabetic hemodialysis patients: a cohort study , 2018, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[2]  S. Nakai,et al.  FP655EFFECTS OF DIALYZER MEMBRANE MATERIALS ON SURVIVAL IN CHRONIC HEMODIALYSIS PATIENTS: A 2-YEAR COHORT STUDY FROM THE ANNUAL SURVEY OF THE JAPANESE RENAL DATA REGISTRY , 2018 .

[3]  S. Nakai,et al.  Is there a "burnt-out diabetes" phenomenon in patients on hemodialysis? , 2017, Diabetes research and clinical practice.

[4]  S. Nakai,et al.  High-Performance Membrane Dialyzers and Mortality in Hemodialysis Patients: A 2-Year Cohort Study from the Annual Survey of the Japanese Renal Data Registry , 2017, American Journal of Nephrology.

[5]  Chul-woo Yang,et al.  The atherogenic index of plasma and the risk of mortality in incident dialysis patients: Results from a nationwide prospective cohort in Korea , 2017, PloS one.

[6]  T. Hasegawa,et al.  Peritoneal Dialysis Registry With 2013 Survey Report , 2016, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

[7]  A. Gorke.  Dialysis Outcomes and Practice Patterns Study (DOPPS) , 2016, Dialyse aktuell.

[8]  K. Yokoyama,et al.  Clinical efficacy of combined therapy with peritoneal dialysis and hemodialysis , 2016, Renal Replacement Therapy.

[9]  Chul-woo Yang,et al.  Glycemic Control Modifies Difference in Mortality Risk Between Hemodialysis and Peritoneal Dialysis in Incident Dialysis Patients With Diabetes , 2016, Medicine.

[10]  T. Hasegawa,et al.  Peritoneal Dialysis Registry With 2012 Survey Report , 2015, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

[11]  K. Wakai,et al.  An Overview of Regular Dialysis Treatment in Japan (As of 31 December 2013) , 2015, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

[12]  K. Kalantar-Zadeh,et al.  Haemodialysis-induced hypoglycaemia and glycaemic disarrays , 2015, Nature Reviews Nephrology.

[13]  T. Nakao,et al.  Combined Therapy with Peritoneal Dialysis and Hemodialysis: A Multicenter Retrospective Observational Cohort Study in Japan , 2014, Blood Purification.

[14]  O. Dekkers,et al.  Survival in dialysis patients is not different between patients with diabetes as primary renal disease and patients with diabetes as a co-morbid condition , 2011, BMC nephrology.

[15]  M. Ikeda,et al.  Clinical impact of a combined therapy of peritoneal dialysis and hemodialysis. , 2010, Clinical nephrology.

[16]  B. Piraino,et al.  PERITONEAL DIALYSIS-RELATED INFECTIONS RECOMMENDATIONS: 2010 UPDATE , 2010, Peritoneal Dialysis International.

[17]  M. Tuncer,et al.  Advanced oxidative protein products are independently associated with endothelial function in peritoneal dialysis patients , 2009, Nephrology.

[18]  D. Naimark,et al.  Patient and technique survival of diabetics on peritoneal dialysis: one-center's experience and review of the literature. , 2008, Clinical nephrology.

[19]  K. Kalantar-Zadeh,et al.  Chronic peritoneal dialysis in the United States: declining utilization despite improving outcomes. , 2007, Journal of the American Society of Nephrology : JASN.

[20]  W. Winkelmayer,et al.  Comparison of hemodialysis and peritoneal dialysis survival in The Netherlands. , 2007, Kidney international.

[21]  David W. Johnson,et al.  Higher peritoneal transport status is associated with higher mortality and technique failure in the Australian and New Zealand peritoneal dialysis patient populations. , 2005, Journal of the American Society of Nephrology : JASN.

[22]  B. Lindholm,et al.  Peritoneal dialysis patient survival: a comparison between a Swedish and a Korean centre. , 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[23]  R. Foley,et al.  The differential impact of risk factors on mortality in hemodialysis and peritoneal dialysis. , 2004, Kidney international.

[24]  K. Fushimi,et al.  An Overview of Regular Dialysis Treatment in Japan (as of 31 December 2002) † , 2004, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

[25]  David W. Johnson,et al.  Predictors of baseline peritoneal transport status in Australian and New Zealand peritoneal dialysis patients. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[26]  M. Nakayama,et al.  Review of Combination of Peritoneal Dialysis and Hemodialysis as a Modality of Treatment for End‐stage Renal Disease , 2004, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

[27]  R. Wolfe,et al.  Association of comorbid conditions and mortality in hemodialysis patients in Europe, Japan, and the United States: the Dialysis Outcomes and Practice Patterns Study (DOPPS). , 2003, Journal of the American Society of Nephrology : JASN.

[28]  R. Fluck,et al.  Glycemic control in diabetic CAPD patients assessed by continuous glucose monitoring system (CGMS). , 2003, Kidney international.

[29]  S. Davies,et al.  Quantifying comorbidity in peritoneal dialysis patients and its relationship to other predictors of survival. , 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[30]  C. Holmes,et al.  Strategies to Reduce Glucose Exposure in Peritoneal Dialysis Patients , 2000, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[31]  D. Choudhury,et al.  Advanced glycation end products: a Nephrologist's perspective. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[32]  F. Valderrábano.  Renal replacement therapy. What are the differences between Japan and Europe? , 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[33]  F. Port,et al.  Five-year survival for end-stage renal disease patients in the United States, Europe, and Japan, 1982 to 1987. , 1990, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[34]  Y. Maruyama.  Does Combined Therapy with Peritoneal Dialysis and Hemodialysis Improve Prognosis? , 2018, Contributions to nephrology.

[35]  S. Nakai,et al.  An overview of regular dialysis treatment in Japan (As of December 31, 2012) , 2014 .

[36]  Ross Ward,et al.  United States Renal Data System , 2011 .